Insider · CIK 0001385496

Stonehouse Jon P

CIK 0001385496 Name as filed on the most recent filing

Filed as Stonehouse Jon P (22)

31 transaction lines · from 22 filings · filed 2007-08-02 to 2024-05-15 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

31 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-05-13 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 166,500, acquired Open Form 4 filing 0001127602-24-015365
2023-02-01 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 1,038,000, disposed Open Form 4 filing 0001127602-23-003172
2022-12-15 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 153,690, disposed Open Form 4 filing 0001127602-22-027894
2022-12-02 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 1,057,997, disposed Open Form 4 filing 0001127602-22-026832
2022-12-01 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 2,793,921, disposed Open Form 4 filing 0001127602-22-026832
2022-01-11 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 2,767,360, disposed Open Form 4 filing 0001127602-22-001458
2020-12-15 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 1,117,193, disposed Open Form 4 filing 0001127602-20-031780
2019-11-18 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 72,500, acquired Open Form 4 filing 0001127602-19-033035
2018-12-03 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 729,600, disposed Open Form 4 filing 0001127602-18-035394
2018-11-09 P, Open-market purchase Bellicum Pharmaceuticals, IncBLCM 45,600, acquired Open Form 4 filing 0001358403-18-000102
2015-06-19 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 300,400, disposed Open Form 4 filing 0001127602-15-021137
2012-03-02 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 13,006, disposed Open Form 4 filing 0001127602-12-009583
2011-08-08 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 25,190, acquired Open Form 4 filing 0001127602-11-023086
2011-03-18 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 33,988, acquired Open Form 4 filing 0001127602-11-010718
2009-01-30 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 4,845, acquired Open Form 4 filing 0001127602-09-002348
2008-12-01 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 81,450, acquired Open Form 4 filing 0000882796-08-000041
2008-11-03 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 2 lines 43,729, acquired Open Form 4 filing 0000882796-08-000039
2008-08-12 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 7,124, acquired Open Form 4 filing 0000882796-08-000037
2008-08-11 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 22,736, acquired Open Form 4 filing 0000882796-08-000035
2008-08-04 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 677, acquired Open Form 4 filing 0000882796-08-000031
2008-01-31 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 10,506, acquired Open Form 4 filing 0000882796-08-000004
2007-08-14 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 26,129, acquired Open Form 4 filing 0000882796-07-000054
2007-08-13 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 7 lines 71,863, acquired Open Form 4 filing 0000882796-07-000054
2007-07-31 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 17,376, acquired Open Form 4 filing 0000882796-07-000050

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 22
  • Open-market sale 9
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Stonehouse Jon P, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001385496

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.